Day: February 28, 2020

Selskabsmeddelelse nr. 4/2020Grindsted, den 28. februar 2020Den Jyske Sparekasse afholder ordinær generalforsamlingtirsdag d. 24. marts 2020, kl. 16.00I henhold til vedtægternes pkt. 7 indkaldes hermed til ordinær generalforsamling i                      Den Jyske Sparekasse A/STirsdag, den 24. marts 2020 på Hotel Legoland, Åstvej 10, 7190 Billund.Dagsorden:1. Bestyrelsens beretning om sparekassens virksomhed i det forløbne år.5. Valg af revisor.Bestyrelsen foreslår genvalg af Deloitte Statsautoriseret Revisionspartnerselskab i overensstemmelse med revisionsudvalgets indstilling. Revisionsudvalget er ikke blevet påvirket af tredjeparter og har ikke været underlagt nogen aftale med en tredjepart, som begrænser generalforsamlingens valg af visse revisorer eller revisionsfirmaer.6. Bemyndigelse til køb af egne aktier.Bestyrelsen foreslår,...

Lima, Feb. 28, 2020 (GLOBE NEWSWIRE) — Lima, PERU, February 27th, 2020– Credicorp Ltd. is pleased to announce the director candidates for its 2020 Annual General Shareholders Meeting scheduled for Friday, March 27, 2020, at 3 p.m. (Peru time), at the main offices of Banco de Credito del Peru, located at Calle Centenario 156, Urb. Las Laderas de Melgarejo, La Molina, Lima, Peru.Consistent with our focus on maintaining governance structures which help drive long-term stakeholder value and demonstrating leadership on corporate governance, Credicorp’s Board of Directors proposes three new independent director candidates for election. Collectively the three new candidates would add to Credicorp’s board deep professional expertise in retail and digital banking, insurance, management consulting, retail marketing, private equity and law....

Selskabsmeddelelse nr. 3/2020Grindsted, den 28. februar 2020Bruttolønsordning – medarbejderaktieprogram i 2. halvår af 2020Bestyrelsen i Den Jyske Sparekasse har truffet beslutning om, at der arbejdes mod at igangsætte et medarbejderaktieprogram i 2. halvår af 2020.Medarbejderaktieprogrammet vil være baseret på aftaler om kontantlønsnedgang og vil ske inden for rammerne af Ligningslovens § 7P. Medarbejderne vil kunne erhverve aktier for op til 20 % af deres bruttoløn, og aktierne vil i henhold til programmet kunne erhverves til en favørkurs på op til 13 % i forhold til markedskursen. Aktier erhvervet i henhold til ordningen vil ikke kunne overdrages i en periode på minimum 6 måneder efter erhvervelsen.Programmet vil løbe over 12 måneder, og omfattede personer vil være direktionen og alle medarbejdere ansat i Den Jyske Sparekasse.Sparekassen...

København, Feb. 28, 2020 (GLOBE NEWSWIRE) —På grund af den generelle øget volatilitet på de finansielle markeder grundet COVID-19 sker der en midlertidig forhøjelse af det maksimale emissionstillæg og det maksimale indløsningsfradrag på følgende afdelinger:Hvis der er spørgsmål, kontakt da Head of Middle Office Steen Vittrup på telefon 77 30 90 16.Med venlig hilsenBI Management A/SMalene EhrenskjöldDirektør

NEW YORK, Feb. 28, 2020 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Mark Pruzanski, M.D., President and Chief Executive Officer of Intercept, will present at the Cowen 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020 at 8:00 a.m. ET.A live webcast of the event will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept’s website for approximately two weeks.About InterceptIntercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases,...

AUSTIN, Texas, Feb. 28, 2020 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that management will present a corporate overview at the Cowen & Company 40th Annual Health Care Conference, the Barclays Global Healthcare Conference, and the Oppenheimer 30th Annual Healthcare Conference.About Molecular Templates  Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Molecular Templates’ proprietary drug platform technology, known as engineered toxin bodies, or ETBs,...

PITTSBURGH, Feb. 28, 2020 (GLOBE NEWSWIRE) — II‐VI Incorporated (Nasdaq: IIVI)What: II-VI Incorporated, a global leader in engineered materials and optoelectronic components, today announced multiple speakers for the upcoming 2020 OIDA Executive Forum and other events at OFC, the Optical Networking and Communication Conference and Exhibition. Topics will focus on executive business perspectives and technology driving the future of the optical communications industry.Where: San Diego Convention Center in California, USA.When: March 9-12, 2020.Who: II-VI thought leaders include:Chuck Mattera, Chief Executive OfficerEvent: 2020 OIDA Executive ForumTitle: Fireside Chat: The View From the TopDate/Location: March 9 at 4:10 p.m. at the Hilton Bayfront HotelSanjai Parthasarathi, Chief Marketing OfficerEvent: OFC Exhibit Hall Theater SpeakerTitle:...

Houston, Feb. 28, 2020 (GLOBE NEWSWIRE) — Today, Shell Midstream Partners, L.P. (NYSE: SHLX) (the “Partnership” or “SHLX”) announced it has signed an agreement with its general partner to eliminate all incentive distribution rights (“IDRs”) and economic general partner (“GP”) interest in SHLX. SHLX has also entered into a Purchase and Sale Agreement with affiliates of its sponsor, Royal Dutch Shell plc (“Shell”), to acquire (i) Shell’s 79% interest in Mattox Pipeline Company LLC, which owns the Mattox Pipeline, and (ii) certain logistics assets at the Shell Norco Manufacturing Complex. As consideration for the assets and the elimination of IDRs, the sponsor will receive 160 million newly issued SHLX common units, plus $1.2 billion of Series A perpetual convertible preferred units (the “preferred units”) at a price of $23.63 per unit.“Today...

Press release 28 February 2020Svensk Hypotekspension Fond 4 AB (publ) – Publishing of prospectus and application for admission to trading of notes on Nasdaq StockholmOn 17 December 2019, Svensk Hypotekspension Fond 4 AB (publ) (the “Issuer”) issued, mortgage backed fixed rate notes with ISIN SE0013513371 in the total amount of SEK 2,250,000,000 with final maturity in December 2067 (the “Notes”).The Issuer has prepared a prospectus for the Notes in order to apply for the Notes to be admitted to trading and listed on the corporate bond list of Nasdaq Stockholm. The first day of trading is expected to be on or around 5 March 2020. The prospectus has been approved by and registered with the Swedish Financial Supervisory Authority (Finansinspektionen) on 28 February 2020 in accordance with Regulation (EU) 2017/1129 (the Prospectus Regulation)....

Please see attachment for half year report of 1 July – 31 December 2019AttachmentPWT_IFRS_Kvartalsrapportering Q4 2019 Final